|
|
|
Insider
Information: |
Sachdev Amit |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
71,325 |
|
Indirect Shares
|
7,447 |
|
|
Direct
Value |
$26,012,709 |
|
|
Indirect Value
|
$3,501,430 |
|
|
Total
Shares |
78,772 |
|
|
Total
Value |
$29,514,139 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP Chief Patient & Ex... |
2024-05-15 |
55,325 |
2024-05-15 |
7,447 |
Premium* |
|
Celladon Corp |
CLDN |
|
2022-03-11 |
16,000 |
2020-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-11-04 |
4 |
OE |
$86.52 |
$364,235 |
D/D |
4,097 |
37,513 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-11-04 |
4 |
AS |
$199.77 |
$820,795 |
D/D |
(4,097) |
33,416 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-11-15 |
4 |
AS |
$205.95 |
$11,739 |
D/D |
(57) |
33,416 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-11-25 |
4 |
OE |
$109.14 |
$545,700 |
D/D |
5,000 |
38,416 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-11-25 |
4 |
AS |
$220.00 |
$1,100,000 |
D/D |
(5,000) |
33,416 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-12-09 |
4 |
OE |
$109.14 |
$545,700 |
D/D |
5,000 |
38,416 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-12-09 |
4 |
AS |
$225.00 |
$1,125,000 |
D/D |
(5,000) |
33,416 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-01-08 |
4 |
AS |
$230.00 |
$1,150,000 |
D/D |
(5,000) |
36,190 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-01-08 |
4 |
OE |
$109.14 |
$545,700 |
D/D |
5,000 |
41,190 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-02-03 |
4 |
OE |
$86.52 |
$364,239 |
D/D |
4,097 |
40,287 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-02-03 |
4 |
AS |
$228.89 |
$946,845 |
D/D |
(4,097) |
36,190 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
35,293 |
71,483 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-02-10 |
4 |
D |
$240.95 |
$2,943,204 |
D/D |
(12,215) |
59,268 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-02-11 |
4 |
AS |
$243.53 |
$3,216,311 |
D/D |
(13,070) |
46,198 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-02-17 |
4 |
D |
$241.50 |
$787,773 |
D/D |
(3,262) |
42,936 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-02-18 |
4 |
AS |
$242.04 |
$849,780 |
D/D |
(3,489) |
39,447 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-02-24 |
4 |
D |
$239.23 |
$755,010 |
D/D |
(3,156) |
36,291 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-02-25 |
4 |
AS |
$230.00 |
$788,402 |
D/D |
(3,376) |
32,915 |
0 |
% |
|
CLDN |
Celladon Corp |
Director |
|
2020-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-05-04 |
4 |
AS |
$258.59 |
$11,475,179 |
D/D |
(43,752) |
35,103 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-05-04 |
4 |
OE |
$86.52 |
$4,942,968 |
D/D |
43,752 |
78,855 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-05-05 |
4 |
OE |
$131.89 |
$1,761,523 |
D/D |
13,356 |
48,459 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-05-05 |
4 |
AS |
$265.72 |
$3,606,232 |
D/D |
(13,356) |
35,103 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-05-06 |
4 |
OE |
$131.89 |
$88,234 |
D/D |
669 |
35,772 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-05-06 |
4 |
AS |
$275.28 |
$184,162 |
D/D |
(669) |
35,103 |
0 |
% |
|
193 Records found
|
|
Page 6 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|